Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor

Br J Pharmacol. 1971 Dec;43(4):856-64. doi: 10.1111/j.1476-5381.1971.tb07222.x.

Abstract

1. The hyperactivity and hyperpyrexia produced by L-tryptophan in rats treated with a monoamine oxidase inhibitor was inhibited by chlorpromazine.2. Chlorpromazine did not inhibit the increased rate of synthesis of brain 5-hydroxytryptamine (5-HT) produced by tryptophan loading.3. Hyperactivity and hyperpyrexia were also produced by 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) in rats. Pretreatment with a monoamine oxidase inhibitor potentiated the hyperactivity response. Pretreatment of rats with p-chlorophenylalanine did not inhibit hyperactivity produced by 5-MeODMT.4. Chlorpromazine inhibits hyperactivity caused by tryptophan or 5-MeODMT after monoamine oxidase inhibition either by competition with 5-HT or 5-MeODMT, respectively, at receptor sites or by physiological antagonism.

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism
  • Chlorpromazine / pharmacology*
  • Drug Synergism
  • Fenclonine / pharmacology
  • Fever / chemically induced
  • Humans
  • Hyperkinesis / chemically induced*
  • Male
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Rats
  • Receptors, Drug
  • Serotonin / biosynthesis
  • Tryptamines / antagonists & inhibitors*
  • Tryptamines / pharmacology
  • Tryptophan / antagonists & inhibitors*
  • Tryptophan / pharmacology

Substances

  • Monoamine Oxidase Inhibitors
  • Receptors, Drug
  • Tryptamines
  • Serotonin
  • Tryptophan
  • Fenclonine
  • Chlorpromazine